An In-Depth Conversation: Dr. Thomas Meyer Talks Bentrio with Healio
We’re pleased to share that Bentrio Nasal Spray has been featured during an interview with our CEO and Chairman, Dr. Thomas Meyer with Healio, discussing its innovative formulation and its role in addressing seasonal allergic rhinitis symptoms.
In the interview, Dr. Meyer explains the functionality of Bentrio, which creates a protective gel layer in the nasal cavity, defending against various airborne allergens, including pollen and dust mites. He emphasizes how Bentrio was inspired by the natural defence mechanisms of our bodies and enhances this protection, offering a practical solution for individuals with allergies.
The conversation also covers the outcomes of the NASAR trial, where Bentrio was tested in real-life conditions for 14 days, showing a notable reduction in Total Nasal Symptom Scores compared to a saline spray group. These findings indicate a meaningful improvement in patients’ quality of life.
Dr. Meyer mentions the swift onset of Bentrio’s effects from the first day of treatment, especially for those with moderate to severe symptoms. The interview further touches on Bentrio’s FDA clearance for alleviating mild allergic symptoms and discusses the next steps towards commercialization.
